Home >Medication Guide

Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Related Articles

  • Brigatinib(Alunbrig)

    The treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：85

  • Koselugo(Selumetinib)

    Koselugo is suitable for treating children aged 2 years and above with type 1 neurofibromatosis.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：144

  • Alpelisib(Piqray)

    Alpelisib combined with Fluvastatin in the treatment of postmenopausal women and men with breast cancer.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：140

  • Balversa(Erdafitinib)

    Balversa is suitable for treating adult patients with locally advanced or metastatic urothelial carcinoma.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：183

  • Stiripentol(Diacomit)

    Stiripentol is suitable for treating epileptic seizures associated with Dravet syndrome (DS).【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：181

  • Fidaxomicin(Dificid)

    Used for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults and children aged 6 months and older.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：154

  • Ponatinib(Iclusig)

    Chronic Myeloid Leukemia‌ and Acute Lymphoblastic Leukemia‌.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：137

  • Lenvatinib(Lenvima)

    Lenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma (EC).【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：32

  • Tucatinib(Tukysa)

    Tucatinib can be used to treat breast cancer and colorectal cancer in adult patients.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：114

  • Vigabatrin(Sabril)

    Vigabatrin is an adjuvant therapy for refractory complex partial epilepsy patients aged 2 years and above.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：98

  • Entrectinib(Rozlytrek)

    Entrectinib is a Broad-spectrum antitumor agents.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：56

  • Upadacitinib(Rinvoq)

    Upadacitinib can regulate abnormal immune responses, alleviate inflammation and symptoms of diseases.【more】
    Article source：Captain MedicineRelease date：2026-01-05Recommended：91

News

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Hospital Departments
Latest Articles
Medicine Updates

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Product

Product

Contact US

Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

  • Whatsapp

    Name: Lucius

  • Telegram name: Vira

    No.:0085253923643

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved Lucius Pharmaceuticals Lucius Laos 老挝全球药房

WhatsApp

Telegram name: Vira

No.:0085253923643